Stock LXRX LEXICON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lexicon Pharmaceuticals, Inc.

Equities

LXRX

US5288723027

Real-time Estimate Cboe BZX
Other stock markets
 16:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
1.97 USD +2.60% Intraday chart for Lexicon Pharmaceuticals, Inc. +8.05% +25.00%
05-14 Transcript : Lexicon Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
05-14 Lexicon Pharmaceuticals Says Post Hoc Analysis of Infepa Trial Showed Decreased Heart Failure Risk; Shares Gain Pre-Bell MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LEXICON PHARMACEUTICALS, INC. Stock Lexicon Pharmaceuticals, Inc.
 694M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. LXRX Stock
  4. Charts Lexicon Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW